These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22112534)

  • 1. Dissemination of extended-spectrum β-lactamase-producing Escherichia coli at home: a potential occupational hazard for healthcare workers?
    Cotter M; Boyle F; Khan A; Boo TW; O'Connell B
    J Hosp Infect; 2012 Jan; 80(1):100-1. PubMed ID: 22112534
    [No Abstract]   [Full Text] [Related]  

  • 2. Importation of KPC-2-producing Escherichia coli from India.
    Potron A; Poirel L; Verdavaine D; Nordmann P
    J Antimicrob Chemother; 2012 Jan; 67(1):242-3. PubMed ID: 21969332
    [No Abstract]   [Full Text] [Related]  

  • 3. New Delhi metallo-beta-lactamase: a cautionary tale.
    Muir A; Weinbren MJ
    J Hosp Infect; 2010 Jul; 75(3):239-40. PubMed ID: 20435372
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergence of the IMP-8 metallo-β-lactamase in the Escherichia coli ST131 clone in Taiwan.
    Yan JJ; Tsai LH; Wu JJ
    Int J Antimicrob Agents; 2012 Sep; 40(3):281-2. PubMed ID: 22789726
    [No Abstract]   [Full Text] [Related]  

  • 5. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.
    Chihara S; Okuzumi K; Yamamoto Y; Oikawa S; Hishinuma A
    Clin Infect Dis; 2011 Jan; 52(1):153-4. PubMed ID: 21148536
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Lee NY; Huang WH; Tsui KC; Hsueh PR; Ko WC
    Diagn Microbiol Infect Dis; 2011 May; 70(1):150-3. PubMed ID: 21398070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
    Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.
    Paterson DL; Singh N; Gayowski T; Marino IR
    Clin Infect Dis; 1999 Mar; 28(3):683-4. PubMed ID: 10194100
    [No Abstract]   [Full Text] [Related]  

  • 9. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
    J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
    [No Abstract]   [Full Text] [Related]  

  • 10. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
    Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
    Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O
    Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions.
    Mendonça N; Louro D; Castro AP; Diogo J; Caniça M
    J Antimicrob Chemother; 2006 May; 57(5):1014-6. PubMed ID: 16531434
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Cueto Md; Gálvez J; Perea EJ; Pascual A
    Clin Microbiol Infect; 2008 Feb; 14(2):180-3. PubMed ID: 18005358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children's hospital.
    Devrim I; Gulfidan G; Gunay I; Agın H; Güven B; Yılmazer MM; Dizdarer C
    Expert Opin Pharmacother; 2011 Apr; 12(6):845-9. PubMed ID: 21323503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum β-lactamase (ESBL) and non-ESBL producing Escherichia coli.
    Hsieh CJ; Shen YH; Hwang KP
    J Microbiol Immunol Infect; 2010 Jun; 43(3):240-8. PubMed ID: 21291853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
    Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America.
    Araque M; Millán B; Mendoza E; Salas M
    J Infect Dev Ctries; 2013 May; 7(5):432-5. PubMed ID: 23669435
    [No Abstract]   [Full Text] [Related]  

  • 20. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.
    Mantengoli E; Luzzaro F; Pecile P; Cecconi D; Cavallo A; Attala L; Bartoloni A; Rossolini GM
    Clin Infect Dis; 2011 Mar; 52(5):690-1. PubMed ID: 21220769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.